Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

4.48USD
19 Dec 2014
Price Change (% chg)

$0.03 (+0.67%)
Prev Close
$4.45
Open
$4.44
Day's High
$4.48
Day's Low
$4.24
Volume
784,289
Avg. Vol
293,081
52-wk High
$6.16
52-wk Low
$3.04

IMMU.OQ

Chart for IMMU.OQ

About

Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either... (more)

Overall

Beta: 0.84
Market Cap (Mil.): $417.24
Shares Outstanding (Mil.): 93.13
Dividend: --
Yield (%): --

Financials

  IMMU.OQ Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -0.48 -- --
ROI: -127.79 -0.72 18.25
ROE: -133.38 -1.88 19.13
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $31.94 -0.03
Roche Holding Ltd. (ROG.VX) CHF270.40 -18.30
Bayer AG (BAYGn.DE) €114.00 -1.00
Bayer AG (BAYE.F) -- --
AstraZeneca plc (AZN.L) 4,565.00p -7.50
GlaxoSmithKline plc (GSK.L) 1,392.00p +13.50
Eli Lilly and Co (LLY.N) $72.40 -0.05
Bristol-Myers Squibb Co (BMY.N) $61.30 +0.51
Bristol-Myers Squibb Co (BMYMP.PK) $980.15 --
Amgen, Inc. (AMGN.OQ) $170.17 +1.69

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks